MVCAX
Price
$34.06
Change
+$0.04 (+0.12%)
Updated
Jul 13 closing price
Net Assets
17.25B
MVEIX
Price
$12.85
Change
-$0.02 (-0.16%)
Updated
Jul 13 closing price
Net Assets
20.1M
Interact to see
Advertisement

MVCAX vs MVEIX

MVCAX vs MVEIX Comparison Chart in %
View a ticker or compare two or three
VS
MVCAX vs. MVEIX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVCAX is a Hold and MVEIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.2B vs. MVEIX (20.1M). MVCAX pays higher dividends than MVEIX: MVCAX (1.11) vs MVEIX (0.71). MVCAX was incepted earlier than MVEIX: MVCAX (25 years) vs MVEIX (28 years). MVEIX (1.48) is less costly to investors than MVCAX (0.98). MVEIX is a more actively managed with annual turnover of: 54.00 vs. MVCAX (24.00). MVCAX has a lower initial minimum investment than MVEIX: MVCAX (1000) vs MVEIX (10000). MVEIX annual gain was more profitable for investors over the last year : 17.18 vs. MVCAX (9.45). MVCAX return over 5 years is better than : 17.60 vs. MVEIX (8.64).
MVCAXMVEIXMVCAX / MVEIX
Total Expense Ratio0.971.4866%
Annual Report Gross Expense Ratio0.981.4866%
Fund Existence25 years28 years-
Gain YTD13.13612.939102%
Front Load6%N/A-
Min. Initial Investment10001000010%
Min. Initial Investment IRAN/AN/A-
Net Assets17.2B20.1M85,572%
Annual Yield % from dividends1.110.71156%
Returns for 1 year9.4517.1855%
Returns for 3 years20.0631.2964%
Returns for 5 years17.608.64204%
Returns for 10 years82.5718.26452%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCDAX49.03N/A
N/A
Fidelity Advisor Stock Selector Sm Cp A
SRIGX14.28N/A
N/A
Gabelli SRI AAA
EIVFX15.10N/A
N/A
Allspring Special Large Cap Value R6
EPDIX14.37N/A
N/A
EuroPac International Dividend Income I
DSMFX17.15N/A
N/A
Destinations Small-Mid Cap Equity I